cabozantinib
exelixis
['atlantis', 'cabozantinib', 'muc ,(-much)']
pr. robert jones presents the final analysis of atlantis: cabozantinib does not yield survival advantages as maintenance therapy after chemotherapy in muc #asco22 
Director, @danaFarber_GU & International Strategic Initiatives @DanaFarber. Kohlberg Prof. of Medicine @Harvardmed. @PanMass rider. #SoccerIsLife. Views Mine.